Bharat Biotech to ramp up Covaxin production

Bharat Biotech will ramp up the production of Covaxin to produce 700 million doses annually. The announcement on expanding the production comes a day after the Central Government approved Rs 1,500 crore funding for vaccine manufacture and supplies.

The announcement comes a day after Central Government nod to extend funding of about ₹1,500 crore for vaccine manufacture and supplies.

Manufacturing partnerships are being explored with partners in other countries, who have prior expertise with commercial scale manufacture of inactivated viral vaccines under biosafety containment.